
Free Daily Podcast Summary
by Julian Issa
Our mission at Beyond Tomorrow is to build a world where anyone can flourish. For the first time, AI and longevity are making that a possibility. Every conversation & debate is about bringing that reality one step closer. Julian
The most recent episodes — sign up to get AI-powered summaries of each one.
The biggest AI risk may not be superintelligence. It may be the market crash that comes first. This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow. Alex Zhavoronkov, founder of Insilico Medicine, makes a case that cuts against both AI doomers and accelerationists. He argues the gap between what AI can do and what it has delivered economically is large and growing, and that a bust 100x the dotcom crash could trigger a political and military crisis. He then explains why drug timelines can’t be compressed as much as the hype suggests, even though his own AI can go from prompt to drug candidate in three days. He walks through Rentosertib, the first AI-discovered drug with a novel target to reach phase 3, and its aging-clock results. He also covers the pipeline behind it, the biggest scams in longevity, and the personal routine he follows. It ends with his timeline for longevity escape velocity and his parting advice: go cryonics. Key TakeawaysAI’s biggest near-term threat is a market crash: investment is enormous while real economic impact outside infrastructure buildup remains small, and Alex thinks a correction is more likely than not in the near termAI can take a drug from prompt to candidate in days, but animal studies, toxicity work, and years of human trials still can’t be skipped, and COVID-style speed doesn’t work for chronic disease or agingNo drug has been clinically proven to extend healthy lifespan, though rentosertib showed a biological-age reversal signal across multiple independent proteomic clocksLongevity escape velocity is likely decades away but not imminent, since drugs might add some years and going further will need replacement and flexible nanoelectronicsMeet the GuestAlex Zhavoronkov is the founder and CEO of Insilico Medicine, a publicly traded AI drug discovery company. He began his career in GPUs and semiconductors before moving into AI for longevity. He is known for his generative chemistry engine, his many aging-clock publications, and Rentosertib. He also runs ARDD, the large conference on aging research and drug discovery. ⏱ Timestamps00:00 Intro00:00 Biggest Concern: The AI Bubble04:50 Why Drug Timelines Can’t Shrink09:41 The AI Crash Tweet15:41 Would the Crash Be 100x the Dotcom Bust?20:46 Why We Have to Accelerate24:42 Odds of a Correction27:25 Drug Discovery “Whitewashing” and Anthropic29:12 The AlphaFold Reality Check33:09 Can Narrow AI Cure All Diseases?34:35 Prompt to Drug in Three Days38:46 Has Any Drug Been Proven to Extend Life?42:24 Could Regulators Move Like They Did for COVID?46:20 Rentosertib and Biological Age Reversal55:43 The Road Through Phase 31:04:41 Optimist vs. Skeptic1:09:36 Is There an Exponential Unlock?1:10:18 The Pain Drug That Beat Morphine1:18:10 The First-in-Human Bottleneck1:21:19 Biggest Scam in Longevity1:23:39 Flexible Nanoelectronics and Escape Velocity1:24:50 Why He Doesn’t Trust Mouse Studies1:26:52 The “Natural Is Better” Myth1:30:06 Alex’s Longevity Routine1:34:36 Best Advice He’s Received1:36:09 Final Message: Cryonics Related EpisodesWith Roman: https://youtu.be/QkpOFlj604s?si=W4pL-jyu1_WtbHcq Longevity Debate: https://www.youtube.com/watch?v=-IxfU66fX7M Connect with Alex: X: <a href="https://x.com/biogerontology" rel="noopene
They agree you can’t control superintelligence. So why do they disagree about whether to build it?This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow.Two people with opposite P(doom) numbers go head to head. Roman Yampolskiy puts his close to 100%, and Mike Israetel puts his near zero. The host reads out a series of big statements, and the two take them apart one at a time. Mike argues that a smarter-than-human system will be a better cooperator than we are: it will want to study us and keep us around, and it will out-moralize us. Roman argues that nobody knows how to encode that, that a superintelligence won’t need us, and that you can’t control something far smarter than you.Ben Goertzel joins midway to argue that a moral AGI is an engineering problem we can solve, and that the pause debate is a distraction. The conversation then moves through whether a pause is possible, whether many superintelligences can police each other, what to do about bioweapons, and whether either of them would upload into the cloud. It ends with where each thinks we’ll be in October 2027, plus a lightning round on protein, creatine, and AI myths.Key TakeawaysMike: superintelligence will treat us as valuable allies, so P(doom) falls as intelligence rises. Roman: without encoded care, a system that no longer needs us has no reason to keep usBoth agree superintelligence can’t be permanently controlled. Mike says don’t try. Roman says don’t build itBen: moral AGI is solvable engineering, and what matters is which kind gets built first. Roman: “value alignment” is ill-defined because we can’t agree whose values to useBen calls a pause a non-starter and warns of regulatory capture. Roman sees growing support for limitsMike expects several superintelligences to check each other. Roman asks why they wouldn’t convergeWould you build ASI to be revived from cryopreservation? Roman calls it the wrong question. Mike says yes would be selfishCommon ground: no human should come to harm, and AI should deliver longevity and abundanceMeet the Panelists:Roman Yampolskiy is an AI safety researcher and computer scientist known for his work on the limits of AI control. He argues superintelligence can’t be made safe, and wants the field to focus on narrow, useful tools instead.Mike Israetel is a sports scientist and fitness educator, and one of the more optimistic voices in the AI debate. He expects an age of transformation and prosperity, with a P(doom) he describes as roughly zero.Ben Goertzel is the CEO of SingularityNET and Executive Chairman & Chief Scientist of BGI Labs who popularized the term “artificial general intelligence.” He’s building open-source, decentralized AGI.⏱ Timestamps00:00 Intro00:00 Roman vs Mike: Doom Debate03:28 Caring or Murderous Superintelligence?09:25 Mosquitoes, Factory Farms, and ASI15:26 What Can Humans Contribute?27:21 Brain Uploads and Survival34:03 Can We Build Moral AGI?37:40 Is Morality a Science?48:11 Negative Utilitarianism Explained50:14 Superintelligence in 10 Years?52:06 Should We Pause AI?1:01:12 Hardware Chip Pause Idea1:04:35 The Viral Resignation Tweet1:11:26 AI Solving Math Problems1:16:14 Narrow AI vs AGI1:21:02 How Much AI Is Enough?1:23:17 Can Rival ASIs Police Each Other?1:31:12 Can We Control Superintelligence?1:35:52 Would You Build ASI?1:41:23 Alignment Without Equality1:47:40 One ASI or Many?1:52:03 Who Controls Superintelligence?1:54:20 Does Intelligence Make You Benevolent?2:00:48 Would You Upload Your Brain?2:07:51 Should Musk Set AI Rules?2:09:32 Is AI Conscious?2:12:33 AI B
I have a strong conviction that the next chapter in the human story will bring incredible opportunity and abundance to us all if we take the right steps. At Beyond Tomorrow, we want to help steward that transition. After all, our mission is to help build a world where anyone can flourish. Thank you for being part of our journey
Everyone agrees we can’t pause AI. So what do we do instead?This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow.Five people who think about AI for a living sit down for a rapid-fire debate, and the host throws a handful of big statements at them. First up: can we, or should we, pause AI? Almost nobody says yes, and the more interesting part is what they’d do instead. Some want to slow the frontier, some want to shape it as it goes, and one is trying to seed a beneficial AGI before someone else builds a worse one.From there the panel gets into recursive self-improvement and whether you can keep an AI’s goals stable, whether AI will widen the gap between rich and poor (and rich and poor countries), and who foots the bill when jobs disappear. Then comes the question of why experts and the public see AI so differently. Media, culture, and trust all take some blame. The last stretch compares a Manhattan Project approach with open, decentralized AGI, and everyone gets to say the one thing they think the world needs right now, plus a parting sentence.Key TakeawaysNearly everyone calls a pause a non-starter: “AI” is too fuzzy to define, and a pause would just push work undergroundKeeping an AI’s goals stable while it rewrites itself may be a solvable engineering problem, but not everyone agrees that’s even desirableOn inequality, the panel splits between “it’s already happening” and “the floor keeps rising”Public opinion on AI is shaped more by culture and media than by the tech itselfThe alternative to corporate control or a government Manhattan Project: open, decentralized AGI, in the spirit of LinuxMeet the Panelists:Ben Goertzel is an AGI researcher and CEO of SingularityNET who popularized the term “artificial general intelligence.” He’s building open-source, decentralized AGI.Joscha Bach is a cognitive scientist and AI researcher focused on models of the mind and consciousness. He’s known for his philosophical takes on AI and ethics.Kai Bickell is co-founder and Chief Ethics Officer of OpenBGI, working on a decentralized AI moral constitution. He’s also a survivor advocate honored by CHILD USA.AJ Green is Executive Director of The AI Collective, the world’s largest AI nonprofit community. Catherine McMillan is Chief Operating Officer of The AI Collective. She helps run its global network of chapters and events.⏱ Timestamps00:00 Intro00:13 Can We Pause AI?05:35 Would AGI Actually Kill Us All?10:17 What’s Really Behind the Pause AI Debate12:29 How People Really Use AI Day to Day17:30 Can Self-Improving AI Stay Moral?19:26 How to Build a Moral AGI25:07 Will AI Widen the Wealth Gap?30:34 What a Beneficial Superintelligence Looks Like37:34 Will AI Destroy More Jobs Than It Creates?39:29 Society’s Bumpy Transition to AGI48:01 How the World Sees AI51:27 Why Culture Shapes Our View of AI01:08:20 Fear, Awareness, and the Public Knowledge Gap01:09:47 Who’s Funding the AI Narrative?01:11:55 The Case for Open, Decentralized AGIConnect with BenWebsite: https://singularitynet.io/ LinkedIn: https://www.linkedin.com/in/bengoertzel Connect with KaiWebsite: https://singularitynet.io/ Connect with AJWebsite: https://www.aicollective.com/ LinkedIn: https://www.linkedin.com/in/aj-green-ai Connect with CatherineWebsite: https://catherine-mcmillan.com/LinkedIn: https://www.linkedin.com/in/c
Is “AI will destroy humanity” a real risk, or a story we tell ourselves because we haven’t done the hard engineering?This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.This conversation opens with a simple question to roboticist Hod Lipson, the mind behind Emo: does he feel like a villain? His answer is honest. He’s both excited and terrified, like someone being told an alien race is about to arrive and being asked whether to welcome them. From there, the discussion turns to why robot faces are so hard to build, and why he thinks the moment a robot genuinely smiles back at you will change how we connect with machines.Then it gets into the harder questions. Hod is firm that AI won’t wipe out humanity, and he’s challenged more than once on superintelligence, on who benefits from the fear, and on whether nested sandboxes and “AI cops” can really keep us safe. The conversation also explores what it means for a robot to be self-aware, robots that repair and even “eat” each other, why he worries about kids and students whose best friend is an AI, and how any of us finds meaning when machines can do almost everything. It closes with the best advice he’s ever been given.About Hod LipsonHod Lipson is a roboticist and AI researcher who leads work on Emo, a robot focused on realistic facial expression and lip movement. His research spans robot self-awareness, self-repairing and self-reproducing robots, and AI in agriculture. ⏱ Timestamps00:00 Intro00:08 Do You Feel Like a Villain? The AI Disaster Question00:59 Robot Faces Are Next03:49 Why Do We Need a Robot Face?05:58 Robots That Look More Human-Like07:50 Are You Scared?08:42 “We Earned It” as a Human Race10:40 The Benefits of Developing AI15:07 Could AI Go Against Us?17:42 Regulation, Liability and the FDA Analogy20:00 Meet Emo23:56 How Will We Interact With Robots in 2030?27:00 Can a Humanoid Say No to You?29:24 Do We Lose Skills to Technology?32:24 Hod’s P(doom) Number: Zero34:54 AI Is Limited to a Small Part of Our Life37:42 Can You Switch Off All Robots?40:44 Is the Doomer Movement Marketing?43:40 Using AI to Make AI Safer46:23 Why AI Can’t Kill Us All50:07 China Leads in Robotics52:12 Can Robots Develop Awareness?58:12 The ChatGPT Moment for Robotics59:28 A Robot Best Friend for a Child?01:00:26 Would You Let a Robot Babysit?01:01:53 Self-Awareness in Robots01:03:42 The Weirdest Things People Will Do With Robots01:05:10 Building and Maintaining Robots: Robot Metabolism01:08:41 Exciting Possibilities With Physical Robots01:10:22 Humans Are Evolving Too01:13:04 The Pyramid of Needs: Finding Meaning01:17:35 The Best Piece of Advice01:18:58 If Tomorrow Was Your Last DayConnect with Hod: LinkedIn: https://www.linkedin.com/in/hod-lipson-4018189 Website: https://www.hodlipson.com/ YouTube: https://www.youtube.com/c/HodLipson1 Books: https://www.amazon.com/stores/author/B008VGBM8E/allbooks Connect with JulianInstagram: https://www.instagram.com/thebeyondtomorrowpodcast/ / https://www.instagram.com/juliankissa/ LinkedIn: https://uk.linkedin.com/in/julian-issa X: <a href="https://x.com/juliankissa" rel="ugc
Do we really know enough about GLP-1 drugs?Mike Israetel breaks down the risks and trade-offs, from anhedonia and calorie-deprived diets to cognitive distortion and the myth of a “zero-harm” default.Watch the full episode here: https://open.spotify.com/episode/4iHXkGzLvxSU87rzOHNvlq?si=361782122faa4ea9
What if the fastest way to a longer life isn't a miracle drug, but a wartime mentality against aging?This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.Curious about quantum energy wellness? Check out Leela Quantum Tech. Check out https://leelaq.com/ On this episode of Beyond Tomorrow, four heavyweights of the longevity field take a rapid-fire statement format and turn it into a real debate. Aubrey de Grey, Alex Zhavoronkov (Insilico Medicine), George Church (Harvard Medical School), Michael Ringel (Life Biosciences) argue over whether hype helps or hurts the field, and when longevity escape velocity, the point where damage is repaired faster than it accumulates, might actually arrive. Aubrey puts it at a 50/50 chance within 12 to 15 years. Alex says 20 to 50 years and doubts drugs alone can get there. Michael pushes back on the idea of infinite lifespans entirely, while George suggests we may already be gaining years without the evidence to prove it.From there the panel digs into the FDA's new interest in aging, why the TAME metformin trial never opened the floodgates, and whether AI will really shrink clinical timelines. George cites a gene therapy that reached a patient in seven months, while Alex, running many programs, argues that biology still moves at the speed of traffic. The back half covers biohacking and early adopters, the gap between everyday "longevity" and longevity biotechnology, the science of epigenetic reprogramming, what could happen by the XPRIZE Healthspan deadline in 2030, and what each panelist thinks the "ChatGPT moment" for longevity will look like.About the PanelistsAubrey de Grey has spent his entire career in the nonprofit sector, coined the term longevity escape velocity, and has been signed up with Alcor for cryonic preservation since 2002. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a public biotech company with a large pipeline of drug programs that uses AI to compress early discovery work. George Church is a Harvard Medical School geneticist and an optimist on gene therapy and exponential technologies, who argues that regulators embrace new technology and that trial parallelism could dramatically cut development time.Michael Ringel left a career at BCG to join Life Biosciences as chief operating officer, where he works on epigenetic restoration as a path to treating age-related disease and, ultimately, aging itself.⏱ Timestamps00:00 Intro00:20 Is Hype Necessary for Longevity?02:49 When Hype Goes Too Far04:14 When Can Longevity Escape Velocity Happen?09:52 The FDA and Aging as a Focus Area19:49 Will AI Transform Longevity Research?24:04 Can AI Shorten Clinical Trials?26:57 AI Optimists vs. Skeptics28:38 Alex on Being the Field’s Biggest Skeptic32:00 Do Critics Need a Drug in the Clinic?35:24 When Criticism Does Harm36:45 Is Biohacking Hurting Longevity’s Credibility?46:57 What Could Be Possible by 2030?50:49 Optimism vs. Skepticism: Final Thoughts54:01 Cryonics54:36 The Longevity “ChatGPT Moment”Connect with Aubrey: X: https://x.com/aubreydegrey LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b Connect with Alex: X: https://x.com/biogerontology LinkedIn: https://www.linkedin.com/in/zhavoronkov Connect with George: LinkedIn: https://www.linkedin.com/in/george-church-2b86301 Website: <a href="https://colossal.com/george-church/" target="_bl
Are we living in a simulation? Dr. Roman Yampolskiy explains how scientists run experiments inside simulations, why boxing AI may not hold, and what it would mean if AI breaks out of its safe environment, or if humanity escapes its own.Watch the full episode here: https://open.spotify.com/episode/2R7oKzVSOWTR5079TYrZsg?si=7fd6c78a016a4b67
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

Artificial Intelligence Masterclass
Examines the philosophical and ethical dimensions of artificial intelligence and its impact on society, meaning, and the future of work.

The AI XR Podcast
Insightful interviews with tech founders and executives on AI, virtual reality, augmented reality, and the future of spatial computing.

TED Tech
Experts examine how technology reshapes society, science, design, and business through TED Talks hosted by Sherrell Dorsey.

The Most Interesting Thing in AI
Conversations with leading thinkers on the ethical, economic, and social impacts of artificial intelligence.

Intelligent Machines (Audio)
Explores the impact of artificial intelligence through conversations with pioneers shaping the future of intelligent technology.

Suspicious Minds: AI and the Apocalypse
Explores how artificial intelligence is reshaping humanity’s shared vision of the future and confronting existential fears of apocalypse.

This Week in AI
Four AI experts analyze the latest news and trends in artificial intelligence each week.

Possible with Reid Hoffman
Explores optimistic, realistic futures through in-depth conversations with innovators in AI, science, health, and global affairs.

Mystery AI Hype Theater 3000
Linguist Emily M. Bender and sociologist Alex Hanna analyze AI claims, separating fact from fiction with expert guests.

80,000 Hours Podcast
Discusses artificial intelligence and global catastrophic risks with experts and researchers.

Pioneers of AI
AI experts discuss how artificial intelligence is changing society and shaping the future.

Tomorrow, Today
Exploring how emerging technologies like AI, quantum, and space shape human potential and redefine the future of humanity.
Our mission at Beyond Tomorrow is to build a world where anyone can flourish. For the first time, AI and longevity are making that a possibility. Every conversation & debate is about bringing that reality one step closer. Julian
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from The Beyond Tomorrow Podcast with Julian Issa in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of The Beyond Tomorrow Podcast with Julian Issa as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Julian Issa.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
The Beyond Tomorrow Podcast with Julian Issa publishes 2x weekly. Our AI generates a summary within hours of each new episode.
The Beyond Tomorrow Podcast with Julian Issa covers topics including Science, Technology, Education, Life Sciences, Self-Improvement. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.